On Invalid Date, Bristol Myers Squibb Co (NYSE: BMY) reported Q3 2022 earnings per share (EPS) of $0.75, up 7.14% year over year. Total Bristol Myers Squibb Co earnings for the quarter were $1.61 billion. In the same quarter last year, Bristol Myers Squibb Co's earnings per share (EPS) was $0.70.
As of Q1 2023, Bristol Myers Squibb Co's earnings has grown year over year. Bristol Myers Squibb Co's earnings in the past year totalled $6.68 billion.
What is BMY's earnings date?
Bristol Myers Squibb Co's earnings date is Invalid Date. Add BMY to your watchlist to be reminded of BMY's next earnings announcement.
What was BMY's revenue last quarter?
On Invalid Date, Bristol Myers Squibb Co (NYSE: BMY) reported Q3 2022 revenue of $11.22 billion up 3.49% year over year. In the same quarter last year, Bristol Myers Squibb Co's revenue was $11.62 billion.
What was BMY's revenue growth in the past year?
As of Q1 2023, Bristol Myers Squibb Co's revenue has grown 2.79% year over year. This is 9.57 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.36%. Bristol Myers Squibb Co's revenue in the past year totalled $46.74 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.